Objective: A new member of the MAP kinase family, big MAP kinase-1 (BMK1), has been recently identified to promote cell growth and attenuate apoptosis. P90 ribosomal S6 kinase (p90RSK), one of the potentially important substrates of extracellular signal regulated 1 1 kinase (ERK), regulates gene expression in part via phosphorylation of CREB and the Na / H exchanger. Recently, we have demonstrated that the activity of BMK1, Src (the upstream regulator of BMK1) and p90RSK was increased in hypertrophied myocardium induced by pressure-overload in the guinea pig. However, the abundance and activity of these kinases in human hearts are unknown. Methods: In addition to the three classical MAP kinases (ERK, p38 kinase, and c-Jun NH -terminal kinase (JNK)), we examined the 2 protein expression and activity of Src, BMK1, and p90RSK in explanted hearts from patients with dilated cardiomyopathy (n59). Normal donor hearts, which were not suitable for transplant for technical reasons, were used as controls (n55). Results: There were no significant differences in the levels of protein expression of these kinases between normal and failing hearts. ERK1 / 2 and p90RSK were activated in heart failure compared to control (P,0.01 and P,0.03, respectively), while the activity of p38 kinase was decreased (P,0.05) and the activity of JNK was unchanged in heart failure. By contrast, the activities of Src and BMK1 were significantly reduced in end-stage heart failure compared to normal donor hearts (P,0.05). Conclusion: These data suggest that multiple MAP kinases, p90RSK, and Src are differentially regulated in human failing myocardium of patients with idiopathic dilated cardiomyopathy and may be involved in the pathogenesis of this complex disease.
Introduction
responsible for this complex condition are poorly understood. Activation of the Gaq signaling pathway, which Heart failure is an increasingly important public health includes protein kinase C (PKC), appears to play a critical problem with a high mortality rate. Although a variety of role in the progression of heart failure [1] . Recently, we metabolic and / or neurohumoral factors are implicated in found that translocation of PKC isoforms from cytosolic to the progression of this syndrome, the precise mechanisms membranous fractions were increased in a conventional animal model of heart failure that was induced by pressure-overload [2, 3] and in myocardium from patients with cardiac hypertrophy and failure [5] . Four subfamilies of E-mail address: takeishi@med.id.yamagata-u.ac.jp (Y. Takeishi). 1 Yasuchika Takeishi, Qunhua Huang, and Jun-ichi Abe contributed equally to this work.
Time for primary review 29 days.
MAP kinases have been identified, including extracellular 2.2. Protein preparation signal-regulated kinase (ERK1 / 2), c-Jun NH terminal 2 kinase (JNK), p38 kinase, and big MAP kinase 1 (BMK1 Myocardial samples were immediately frozen in liquid or ERK5) [5] . BMK1 is a recently identified MAP kinase nitrogen after dissection and were stored at 2808C until family member, which shares the TEY activation motif use [4, 12] . The sampling conditions were identical for both with ERK1 / 2 but is activated by MEK5 [6] . It has been failing and non-failing hearts. Fibrotic or adipose tissue, reported that oxidative stress using H O activates ERK1 / endocardium, epicardium, or great vessels were carefully 2 2 2, JNK and p38 kinase in neonatal rat cardiomyocytes [7] , excised, and remaining tissue was homogenized with 4 and ischemia followed by reperfusion activates JNK and vols of ice-cold lysis buffer (50 mM sodium pyrophosp38 kinase in isolated coronary-perfused rat hearts [8] . In phate, 50 mM NaF, 50 mM NaCl, 5 mM EDTA, 5 mM addition, we recently showed that oxidative stress activates EGTA, 100 mM Na VO , 10 mM HEPES, pH 7.4, 1% 3 4 ERK1 / 2 and BMK1 in coronary-perfused isolated adult Triton X-100, 0.1% SDS, 500 mM phenylmethanesulfonyl guinea pig hearts [9] . Each MAP kinase subfamily may be fluoride (PMSF), and 10 mg / ml leupeptin). The heart regulated by different signal transduction pathways that homogenates were centrifuged at 14 0003g (48C for 30 modulate specific cell functions [10] . A potentially immin), and protein concentration was determined using the portant downstream effector of ERK1 / 2 is p90 ribosomal Bradford protein assay (Bio-Rad, Hercules, CA, USA) S6 kinase (p90RSK), which plays a pivotal role in cell [2, 9, 12] . The protein expression and activity of the followgrowth by activating several transcription factors as well as ing kinases were examined in both failing and non-failing
the Na / H exchanger (NHE-1) [11] . human myocardium: ERK1 / 2, P38 kinase, JNK, p90RSK, Although there are considerable data pertaining to MAP Src, and BMK1. kinases in animal models of cardiac hypertrophy and heart failure, data regarding these kinases in the failing human 2.3. Immunoprecipitation and Western blot analysis heart are limited, particularly for p90RSK and BMK1. Accordingly, the purpose of this study was to characterize For immunoprecipitation, cell lysates were incubated the activity of multiple MAP kinases including BMK1 and with rabbit anti-human BMK1 antibody (J.D. Lee, The p90RSK in explanted failing hearts from patients with Scripps Research Institute, La Jolla, CA, USA) for 12 h at idiopathic dilated cardiomyopathy. Of note, we excluded 48C and then incubated with 20 ml of protein A-Sepharose patients with ischemic cardiomyopathy from the present CL-4B (Pharmacia Biotech, Piscataway, NJ, USA) for 1 h study, since it is known that ischemia itself activates on a roller system (RT-50, Taitec, Koshigaya, Saitama, several MAP kinases. Japan) at 48C [9, 13] . The beads were washed two times with 1 ml lysis buffer, two times with 1 ml LiCl wash buffer (500 mM LiCl, 100 mM Tris-HCl, pH 7.6, 0.1% Triton X-100, 1 mM DTT) and two times in 1 ml washing 2. Material and methods buffer (HEPES 20 mM, pH 7.2, 2 mM EGTA, 10 mM MgCl , 1 mM DTT, 0.1% Triton X-100). For Western blot 2 2.1. Patient population analysis, cell lysates or immunoprecipitates were subjected to SDS-PAGE and proteins were transferred to nitroLeft ventricular myocardium was obtained from nine cellulose membranes (Amersham Life Science, Arlington hearts explanted from patients with end-stage heart failure Heights, IL, USA) as previously described [9, 13] . The who were undergoing orthotopic cardiac transplantation membrane was blocked for 1 h at room temperature with a (all men, mean age 41615 years). All patients were commercially available blocking buffer from Gibco BRL diagnosed with New York Heart Association class IV (Life Technologies, Rockville, MD, USA). To examine the congestive heart failure secondary to idiopathic dilated protein expression, the blots were then incubated for 1 h at cardiomyopathy. Non-failing human myocardium was room temperature with anti-BMK1, ERK1, ERK2 (rabbit obtained from five donors (four men and one woman, anti-rat, cross-reactive with human; Santa Cruz Biotechmean age 44619 years), who had sustained traumatic brain nology, Santa Cruz, CA, USA), p38 kinase (rabbit antideath; these donors had normal cardiac function (as human; Santa Cruz Biotechnology), JNK1, JNK2 (rabbit assessed echocardiographically) and had not been preanti-human; Santa Cruz Biotechnology), p90RSK (goat scribed cardiovascular medications. The normal donor anti-human; Santa Cruz Biotechnology), or Src (rabbit hearts were not used for transplantation because of technianti-human; Santa Cruz Biotechnology), followed by cal reasons, such as death of the recipient, logistic probincubation for 1 h with secondary antibody conjugated lems, signs of chest trauma after explantation, etc. The with horse radish peroxidase (KPL laboratories, Gaithinvestigation conforms with the principles outlined in the esburg, MD, USA). Immunoreactive bands were visualized Declaration of Helsinki (Cardiovascular Research using enhanced chemiluminescence (ECL, Amersham Life 1997;35:2-3). Science).
2.4. Activity for ERK1 /2, p38 kinase and Src sion between failing and non-failing hearts. However, p90RSK activity was significantly increased (2.160.7-fold, To examine phosphorylation of ERK1 / 2 and p38 ki-P,0.03) in failing myocardium. nase, the blots were incubated for 12 h with anti phosphospecific ERK1 / 2 (mouse anti-human; New England 3.2. Determination of p38 kinase and JNK expression Biolabs, Beverly, MA, USA) and phospho-specific p38
and activity kinase (mouse anti-human; New England Biolabs) antibodies, respectively. We and other investigators have It has been reported that cellular stresses such as previously reported that immunoblotting with phosphohyperosmotic shock, protein synthesis inhibitors (e.g. specific ERK1 / 2 antibody has a good correlation with an anisomycin), hypoxia / reoxygenation, and reactive oxygen immune complex kinase assay [14, 15] . Activity of Src was species activate p38 kinase and JNK in cultured carmeasured using anti activated-Src antibody clone 28 (H.
diomyocytes [5] . To determine the role of p38 kinase and Kawakatsu, University of California San Francisco, San JNK in failing human hearts with idiopathic dilated Francisco, CA, USA), which recognizes only the activated cardiomyopathy, we examined the protein expression and form of Src [9, 13] .
activity of p38 kinase and JNK. As shown in Fig. 2 , although neither the protein expression of p38 kinase, 2.5. p90RSK, JNK, and BMK1 kinase assays JNK1, and JNK2 nor the activity of JNK were significantly different in normal and failing myocardium, the p38 kinase p90RSK kinase activity was measured by glutathione activity (0.460.3-fold, P,0.05) was significantly reduced S-transferase (GST)-NHE-1 phosphorylation and BMK1 in myocardium from failing hearts. kinase activity was measured by autophosphorylation as described previously [9] . JNK activity was measured with 3.3. Src and BMK1 expression and activity in human a commercially available kit (New England Biolabs, failing hearts Beverly, MA, USA) based on phosphorylation of recombinant c-Jun [9] . We could not detect ERK1 / 2, p38, We previously demonstrated that Src kinase regulates p90RSK, or BMK1 in c-Jun fusion protein beads immuno-BMK1 activity in part by oxidative stress in adult guinea precipitates, indicating that JNK is the dominant c-Jun pig hearts [8] . Since reactive oxygen species are known to kinase present (data not shown).
be increased in failing myocardium, we also examined here Src and BMK1 kinases activity. As shown in Fig. 3 , Src 2.6. Statistical analysis and BMK1 protein expression was not different between failing and non-failing myocardium. Src activity, which Data are reported as mean6S.D. Statistical analysis was was evaluated by anti-activated Src-clone 28 antibody, was performed with the StatView 4.0 package (Abacus Condecreased significantly in failing human hearts (0.760.2-cepts, Berkeley, CA, USA). Differences between failing fold, P,0.05). As shown in Fig. 3B , BMK1 activity was and non-failing hearts were analyzed by un-paired t-test. P also decreased in failing human hearts compared to nonvalues less than 0.05 were considered significant. failing hearts (0.460.2-fold, P,0.05).
Results 4. Discussion

ERK1 /2 expression and activity: comparison with
In the present study, we examined whether the expresp90RSK sion and activity of multiple MAP kinases, p90RSK, and Src were altered in ventricular tissue from failed human As determined by quantitative immunoblotting, there hearts with end-stage dilated cardiomyopathy. We found no were no significant differences in the level of ERK1 / 2 differences in protein abundance of these kinases between protein expression between failing human hearts with endfailing and non-failing human hearts. The mean activities stage dilated cardiomyopathy and non-failing human hearts of ERK1 / 2 and p90RSK were significantly greater in (Fig. 1A) . By contrast, the activity of ERK1 / 2 was failing hearts compared to non-failing donor hearts. In increased in failing hearts with dilated cardiomyopathy contrast, p38 kinase, Src, and BMK1 activities were compared to non-failing control hearts (4.260.1-fold, P, reduced in human myocardium with end-stage heart fail-0.01).
ure. We could not detect any significant changes in JNK We also evaluated p90RSK activation in the same activity between failing and non-failing hearts. These data samples, since p90RSK is one of the important downsuggest that the MAP kinase family activity is differentialstream substrates of ERK1 / 2. As shown in Fig. 1B, there ly regulated in human dilated cardiomyopathy without any was no significant difference in p90RSK protein expresalterations in protein abundance. Densitometric analysis revealed that kinase activity of ERK1 / 2 and p90RSK was significantly increased in explanted human failing hearts compared to normal control hearts. IB, immuno-blotting; * P,0.05.
Cook et al. [16] have reported that ERK1 / 2 activity was reported that ERK1 / 2 and p90RSK activation are at least unchanged and p38 kinase activity was increased in failing in part PKC-dependent [17] . ERK1 / 2 were the first MAP human hearts secondary to ischemic cardiomyopathy. In kinases described and it has been reported that ERK1 / 2 our study, the patients were diagnosed as idiopathic dilated activation protects against apoptotic cell death [18, 19] . cardiomyopathy, while in that study they selected patients Among the substrates of ERK, p90RSK is a versatile with heart failure secondary to ischemic cardiomyopathy.
mediator of ERK signal transduction [11, 17] . These inIt has been reported that ischemia and ischemia / reperfuclude: (1) regulation of gene expression via phosphorylasion induced multiple MAP kinase activation [5, 8, 9] . tion of transcription factors including c-fos, cAMP-reTherefore, it is likely that the presence of ischemia itself, sponse element-binding protein (CREB) and CREB-bindin addition to LV dysfunction and heart failure, modulates ing protein, (2) regulation of protein synthesis by phosthe activity of multiple MAP kinases in these patients.
phorylation of polyribosomal proteins and glycogen synth- To our knowledge, this is the first report of p90RSK, Src ase kinase-3, and (3) stimulation of the Na / H exand BMK1 activity in human tissues. We have reported changer by phosphorylating serine 703 of NHE-1 [10] . that protein expression and activity of PKC isoforms are Recently Bonni et al. [19] and Tan et al. [20] reported that elevated in guinea pig model of heart failure by chronic p90RSK phosphorylated the pro-apoptotic protein BAD at pressure-overload [2, 3] and in human explanted hearts serine 112. Phosphorylation of BAD at serine 112 spewith end-stage heart failure [4, 12] . We and others have cifically suppressed BAD-mediated apoptosis. Further in- vestigation is needed to define the precise role of ERK1 / 2 were differentially regulated in human failing myocardium and p90RSK activation in failing human hearts.
of patients with idiopathic dilated cardiomyopathy and Recently, Kato et al. [21] have reported that BMK1 may be involved in the pathogenesis of this clinical activation is also protective against apoptotic cell death.
syndrome. BMK1 is highly expressed in cardiac myocytes and activated by reactive oxygen species in the adult guinea pig heart [8] . Recently, we have demonstrated that BMK1 is activated in hypertrophied myocardium induced by 
